Abstract
In the absence of any “gold standard” next step pharmacologic choice for augmentation of clozapine response, it is gratifying that the coming-on-line- of several neuromodulatory strategies now offer viable alternative treatment approaches. There is evidence that repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for persistent auditory hallucinations. Additionally, electroconvulsive therapy (ECT) continues to have some role in managing refractory schizophrenia. This chapter describes the latest information on several modalities and how/when they should be integrated along the clinical decision-making continuum.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Andrade C (2013) Once- to twice-daily, 3-year domiciliary maintenance transcranial direct current stimulation for severe, disabling, clozapine-refractory continuous auditory hallucinations in schizophrenia. J ECT 29(3):239–242
Bersani FS, Minichino A, Enticott PG et al (2013) Deep transcranial mag-netic stimulation as a treatment for psychiatric disorders: a comprehensive review. Eur Psychiatry 28(1):30–39
Braga RJ, Petrides G (2005) The combined use of electroconvul-sive therapy and antipsychotics in patients with schizophrenia. J ECT 21:75–83
Brunelin J, Mondino M, Gassab L et al (2012) Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry 169(7):719–724
Buchanan RW, Kreyenbuhl J, Kelly DL et al (2010) The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36(1):71–93
Chanpattana W, Chakrabhand ML (2001) Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Res 105:107–115
Chanpattana W, Chakrabhand MLS, Sackeim HA et al (1999) Con-tinuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT 15:178–192
Cohen E, Bernardo M, Masana J et al (1999) Repetitive transcranial mag-netic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry 67:129–130
Demirtas-Tatlidede A, Vahabzadeh-Hagh AM, Pascual-Leone A (2013) Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology 64:566–578
Dlabac-de Lange JJ, Knegtering R, Aleman A (2010) Repetitive transcra-nial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry 71(4):411–418
Flamarique I, Castro-Fornieles J, Garrido JM et al (2012) Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: is it a safe and effective combination? J Clin Psychopharmacol 32(6):756–766
Freitas C, Fregni F, Pascual-Leone A (2009) Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res 108:11–24
Hajak G, Marienhagen J, Langguth B et al (2004) High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treat-ment and neuroimaging study. Psychol Med 34:1157–1163
Hoffman RE, Hawkins KA, Gueorguieva R et al (2003) Transcranial magnetic stimulation of left temporoparietal cortex and medication resistant auditory hallucinations. Arch Gen Psychiatry 60:49–56
Holi MM, Eronen M, Toivonen K et al (2004) Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophr Bull 30:429–434
Jin Y, Kemp AS, Huang Y et al (2012) Alpha EEG guided TMS in schizophrenia. Brain Stimul 5(4):560–568
Johnson KA, Baig M, Ramsey D et al (2012) Prefrontal rTMS for treating depression: Location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul 6(2):108–117
Kindler J, Homan P, Jann K (2013a) Reduced neuronal activity in language-related regions after transcranial magnetic stimulation therapy for auditory verbal hallucinations. Biol Psychiatry 73(6):518–524
Kindler J, Homan P, Flury R et al (2013b) Theta burst transcranial magnetic stimulation for the treatment of auditory verbal hallucinations: results of a randomized controlled study. Psychiatry Res 209(1):114–117
Leiknes KA, Jarosh-von Schweder L, Høie B (2012) Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav 2:283–344
Masoudzadeh A, Khalilian AR (2007) Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pak J Biol Sci 10(23):4287–4290
Mattai A, Miller R, Weisinger B et al (2011) Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia. Brain Stimul 4(4):275–280
Nawani H, Kalmady SV, Bose A et al (2013) Neural basis of tDCS effects on auditory verbal hallucinations in schizophrenia: a case report evidence for cortical neuroplasticity modulation. J ECT (in press)
Nicolson R, Rapoport JL (1999) Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry 46(10):1418–1428
Novak T, Horacek J, Mohr P et al (2006) The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuroendocrinol Lett 27:209–213
Oliveira JF, Zanão TA, Valiengo L et al (2013) Acute working memory improvement after tDCS in antidepressant-free patients with major depressive disorder. Neurosci Lett 537:60–64
Palm U, Keeser D, Blautzik J et al (2013) Prefrontal transcranial direct current stimulation (tDCS) changes negative symptoms and functional connectivity MRI (fcMRI) in a single case of treatment-resistant schizophrenia. Schizophr Res 124:159
Pascual-Leone A, Vills-Sole J, Wasserman EM et al (1994) Responses to rapid rate transcranial magnetic stimulation of the human motor cortex. Brain 117:847–858
Petrides G (2012) Electroconvulsive therapy for medication resistant schizophrenia. Schizophr Res 136(Suppl 1):S22
Poreisz C, Boros K, Antal A et al (2007) Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull 72(4–6):208–214
Rakesh G, Shivakumar V, Subramaniam A et al (2013) Monotherapy with tDCS for Schizophrenia: a case report. Brain Stimul 6(4):708–709
Sachdev P, Loo C, Mitchell P et al (2005) Transcranial magnetic stimula-tion for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry Clin Neurosci 59:354–357
Shiozawa P, da Silva ME, Cordeiro Q et al (2013a) Transcranial direct current stimulation (tDCS) for catatonic schizophrenia: a case study. Schizophr Res 146(1–3):374–375
Shiozawa P, da Silva ME, Cordeiro Q et al (2013b) Transcranial direct current stimulation (tDCS) for the treatment of persistent visual and auditory hallucinations in schizophrenia: a case study. Brain Stimul 6(5):831–833
Slotema CW, Aleman A, Daskalakis ZJ et al (2012) Meta-analysis of re-petitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res 142(1–3):40–45
Tadini L, El-Nazer R, Brunoni AR et al (2011) Cognitive, mood, and electroencephalographic effects of noninvasive cortical stimulation with weak electrical currents. J ECT 27(2):134–140
Zervas IM, Theleritis C, Soldatos CR (2012) Using ECT in schizophrenia: a review from a clinical perspective. World J Biol Psychiatry 13(2):96–105
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rosenquist, P.B., Ahmed, A.O., McCall, W.V. (2014). Therapeutic Brain Stimulation in Treatment-Resistant Schizophrenia. In: Buckley, P., Gaughran, F. (eds) Treatment–Refractory Schizophrenia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45257-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-45257-4_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45256-7
Online ISBN: 978-3-642-45257-4
eBook Packages: MedicineMedicine (R0)